Cite

HARVARD Citation

    Haldrup, C. et al. (n.d.). Large‐scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels. Molecular oncology. 10 (6), pp. 825-837. [Online]. 
  
Back to record